Status:
NOT_YET_RECRUITING
Antimicrobial Strategy for Device Implantation
Lead Sponsor:
University of Calabria
Conditions:
CIED-related Infections
Eligibility:
All Genders
18+ years
Brief Summary
Infections associated with cardiovascular implantable electronic devices (CIEDs) represent one of the major postoperative complications in interventional cardiology. These infections-including lead-re...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Clinical indication for CIED implantation or generator replacement
- Signed informed consent to participate in the study
Exclusion
- Known allergy to taurolidine or any of the excipients
- Severe immunodeficiency status (e.g., patients undergoing chemotherapy, with AIDS, or immunosuppressed following organ transplantation)
- Life expectancy \< 12 months due to severe comorbidities (e.g., metastatic cancer, end-stage organ failure)
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07158502
Start Date
September 1 2025
End Date
December 31 2027
Last Update
September 5 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.